Abstract
In this study it is reported that: (1) the levels of blood platelet-activating factor and serum tumour necrosis factor significantly increased after coronary ligation and reperfusion, compared with sham-ligated controls, in an anaesthetized rat model; (2) compared with vehicle controls, pretreatment with the PAF antagonist BN 50739 (10 mg/kg, i.v.) produced significant decreases in infarct size (from 29.6 ± 4.0% to 22.4 ± 2.1%, p < 0.05 after 3 h ligation, and from 28.5 ± 9.5% to 10.5 ± 4.5%, p < 0.01 after 4 h reperfusion) and the level of serum TNF (from 10.4 ± 7.7 U/ml to 3.9 ± 4.8 U/ml, p < 0.05); and (3) a significan positive correlation was found between the level of blood PAF or serum TNF and infarct size. The present results indicate that PAF and TNF may be important mediators involved in myocardial ischaemia and reperfusion injury, and that PAF antagonists may exert a protective effect on ischaemic or reperfused myocardium by inhibiting the interaction of PAF and TNF.
Full Text
The Full Text of this article is available as a PDF (463.6 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Braquet P., Hosford D., Braquet M., Bourgain R., Bussolino F. Role of cytokines and platelet-activating factor in microvascular immune injury. Int Arch Allergy Appl Immunol. 1989;88(1-2):88–100. doi: 10.1159/000234755. [DOI] [PubMed] [Google Scholar]
- Braquet P., Paubert-Braquet M., Bourgain R. H., Bussolino F., Hosford D. PAF/cytokine auto-generated feedback networks in microvascular immune injury: consequences in shock, ischemia and graft rejection. J Lipid Mediat. 1989 Mar-Apr;1(2):75–112. [PubMed] [Google Scholar]
- Curtis M. J., Macleod B. A., Walker M. J. Models for the study of arrhythmias in myocardial ischaemia and infarction: the use of the rat. J Mol Cell Cardiol. 1987 Apr;19(4):399–419. doi: 10.1016/s0022-2828(87)80585-0. [DOI] [PubMed] [Google Scholar]
- Hirai M., Okamura N., Terano Y., Tsujimoto M., Nakazato H. Production and characterization of monoclonal antibodies to human tumor necrosis factor. J Immunol Methods. 1987 Jan 26;96(1):57–62. doi: 10.1016/0022-1759(87)90367-x. [DOI] [PubMed] [Google Scholar]
- Janero D. R., Burghardt C. Production and release of platelet-activating factor by the injured heart-muscle cell (cardiomyocyte). Res Commun Chem Pathol Pharmacol. 1990 Feb;67(2):201–218. [PubMed] [Google Scholar]
- Joseph R., Welch K. M. Granulocytes, platelet-activating factor, and myocardial injury. Circulation. 1989 Jun;79(6):1401–1401. doi: 10.1161/01.cir.79.6.1401. [DOI] [PubMed] [Google Scholar]
- Koltai M., Hosford D., Guinot P., Esanu A., Braquet P. Platelet activating factor (PAF). A review of its effects, antagonists and possible future clinical implications (Part I). Drugs. 1991 Jul;42(1):9–29. doi: 10.2165/00003495-199142010-00002. [DOI] [PubMed] [Google Scholar]
- Ma X. L., Weyrich A. S., Krantz S., Lefer A. M. Mechanisms of the cardioprotective actions of WEB-2170, bepafant, a platelet activating factor antagonist, in myocardial ischemia and reperfusion. J Pharmacol Exp Ther. 1992 Mar;260(3):1229–1236. [PubMed] [Google Scholar]
- Maury C. P., Teppo A. M. Circulating tumour necrosis factor-alpha (cachectin) in myocardial infarction. J Intern Med. 1989 May;225(5):333–336. doi: 10.1111/j.1365-2796.1989.tb00090.x. [DOI] [PubMed] [Google Scholar]
- Montrucchio G., Alloatti G., Mariano F., de Paulis R., Comino A., Emanuelli G., Camussi G. Role of platelet-activating factor in the reperfusion injury of rabbit ischemic heart. Am J Pathol. 1990 Jul;137(1):71–83. [PMC free article] [PubMed] [Google Scholar]
- Sirois M. G., Plante G. E., Braquet P., Sirois P. Tumor necrosis factor primes the effects of platelet-activating factor on rat vascular permeability. J Lipid Mediat. 1990;2 (Suppl):S109–S117. [PubMed] [Google Scholar]
- Yue T. L., Rabinovici R., Farhat M., Feuerstein G. Inhibitory effect of new PAF antagonists on PAF-induced rabbit platelet aggregation in vitro and ex vivo. J Lipid Mediat. 1991 Jan-Feb;3(1):13–26. [PubMed] [Google Scholar]